Kroatien - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - cisatrakurij besilat - otopina za injekciju / infuziju - 5 mg/ml - urbroj: 1 ml otopine za injekciju ili infuziju sadrži 6,70 mg cisatrakurij besilata, što odgovara 5 mg cisatrakurija

Kroatien - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - ciklofosfamid hidrat - prašak za otopinu za injekciju / infuziju - urbroj: jedna bočica praška za otopinu za injekciju/infuziju sadrži 1069,0 mg ciklofosfamid hidrata, što odgovara 1000 mg ciklofosfamida

Europäische Union - Kroatisch - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Kroatien - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

accord healthcare polska sp. z o.o., ul. lutomierska 50, pabianice, poljska - ciklofosfamid hidrat - prašak za otopinu za injekciju / infuziju - urbroj: 1 bočica 2000 mg ciklofosfamida u obliku ciklofosfamid hidrata, 1 ml rekonstituirane otopine sadrži 20 mg ciklofosfamida.

Kroatien - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - sitagliptinklorid hidrat metforminklorid - tableta s prilagođenim oslobađanjem - urbroj: svaka tableta sadrži 100 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida

Kroatien - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - sitagliptinklorid hidrat metforminklorid - tableta s prilagođenim oslobađanjem - urbroj: svaka tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida

Kroatien - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

apc instytut sp. z o.o., ul. aleje jerozolimskie 146c, varšava, mazowieckei, poljska - sitagliptinklorid hidrat metforminklorid - tableta s prilagođenim oslobađanjem - urbroj: svaka tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 500 mg metforminklorida.

Europäische Union - Kroatisch - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Europäische Union - Kroatisch - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Bosnien und Herzegowina - Kroatisch - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

galenika d.o.o. - protamin - rastvor za injekciju - 50 mg/5 ml - 5 ml rastvora za injekciju sadrži: 50 mg protamin sulfata